SCHEDULE 13G/A: T. Rowe Price Discloses 6.9% Stake in Corpay Inc.
Beneficial Ownership Report
T. Rowe Price Associates, Inc. has filed an amended Schedule 13G, reporting a 6.9% beneficial ownership stake in Corpay Inc. common stock.
Summary
- T. Rowe Price Associates, Inc. reported beneficial ownership of 4,855,736 shares of Corpay Inc. common stock.
- This aggregate amount represents 6.9% of Corpay Inc.'s outstanding common stock.
- T. Rowe Price holds sole voting power over 4,649,623 shares.
- T. Rowe Price holds sole dispositive power over 4,847,406 shares.
- The filing is an Amendment No. 3 to a previous Schedule 13G.
- The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Corpay Inc.
Sentiment
Score: 6
Explanation: The filing is a factual disclosure of beneficial ownership. While not directly about company performance, a significant institutional stake by T. Rowe Price can be interpreted as a positive signal of investor confidence, hence a slightly positive score.
Positives
- A significant stake by a reputable investment adviser like T. Rowe Price can signal institutional confidence in Corpay Inc.'s long-term prospects.
Future Outlook
NA
Industry Context
This filing reflects a standard disclosure by a large institutional asset manager regarding its passive investment in a publicly traded company. Such disclosures are common and provide transparency into significant ownership stakes held by major investment firms across various industries.
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional investor's stake may provide a degree of confidence and stability, potentially influencing market perception positively.
- Management: Awareness of a large, passive institutional holder like T. Rowe Price may influence strategic decisions, though the filing explicitly states the stake is not for control purposes.
Key Dates
| Date | Description |
|---|---|
| 06/30/2025 | Date of event which requires filing of this statement (reporting period end date) |
| 08/14/2025 | Signature date of the Schedule 13G filing |
Keywords
Corpay Inc., T. Rowe Price Associates, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, Investment Adviser, Equity Stake
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.